Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | BHMT | Q93088 | 1/20 | 0.37 |
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144220 | 0.87 | — | — | |
| SCHEMBL2034998 | 0.87 | CYP2D6 (1.00) | CYP2D6HIF1ACYP2C19ALDH1A1EGLN1 | |
| Ammonia Solution, Strong SCHEMBL28227410 | 0.83 | CYP2D6 (0.92) | CYP2D6HIF1ACYP2C19ALDH1A1EGLN1 | |
| Ethylene SCHEMBL28577554 | 0.80 | CYP2D6 (0.86) | CYP2D6HIF1ACYP2C19ALDH1A1HSD17B10 | |
| SCHEMBL13746369 | 0.76 | CYP2D6 (0.56) | CYP2D6HIF1ACYP2C19OR51E2MAPK1 | |
| SCHEMBL9034105 | 0.75 | — | — | |
| SCHEMBL11373474 | 0.75 | — | — | |
| SCHEMBL7900335 | 0.75 | CYP2D6 (0.63) | CYP2D6HIF1ACYP2C19ALDH1A1HSD17B10 | |
| SCHEMBL1324929 | 0.73 | CYP2D6 (0.73) | CYP2D6HIF1ACYP2C19ALDH1A1EGLN1 | |
| SCHEMBL1313188 | 0.73 | CYP2D6 (0.73) | CYP2D6HIF1ACYP2C19ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009089541-A2 | A NEW INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | UNIVERSITY OF KANSAS (US) | 2009-07-16 | — | — | WO | claimed |
| US-8673584-B2 | Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase | UNIVERSITY OF KANSAS (US) | 2014-03-18 | — | — | US | disclosed |
| US-8673584-B2 | Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase | UNIVERSITY OF KANSAS (US) | 2014-03-18 | — | — | US | disclosed |
| US-8673584-B2 | Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase | UNIVERSITY OF KANSAS (US) | 2014-03-18 | — | — | US | disclosed |
| US-20130109031-A1 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | FLORIDA MEMORIAL UNIVERSITY (US) | 2013-05-02 | — | — | US | disclosed |
| US-20130109031-A1 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | FLORIDA MEMORIAL UNIVERSITY (US) | 2013-05-02 | — | — | US | disclosed |
| US-20130109031-A1 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | FLORIDA MEMORIAL UNIVERSITY (US) | 2013-05-02 | — | — | US | disclosed |
| US-20110008461-A1 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | NATIONAL SCIENCE FOUNDATION | 2011-01-13 | — | — | US | disclosed |
| US-20110008461-A1 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | NATIONAL SCIENCE FOUNDATION | 2011-01-13 | — | — | US | disclosed |
| US-20110008461-A1 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | NATIONAL SCIENCE FOUNDATION | 2011-01-13 | — | — | US | disclosed |
| WO-2009089541-A2 | A NEW INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | UNIVERSITY OF KANSAS (US) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008461-A1 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | PCK1, PDXK, PCK2 | CYP2D6 3136/4885HIF1A 2261/4885CYP2C19 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.